From the proteomic analysis, scRNA‐seq and multiple immunofluorescence staining, we further verified that TECs inhibit CD8+ T cells by expressing PD‐L1, which induces T‐cell apoptosis, and helps cancer cells evade immune monitoring and killing, and promoting tumour progression from lepidic to acinar.52, 53. The gene discussed is CD8A; the disease is cancer.